# Lambda Biologics GmbH
> Human-derived organoid models for drug screening, regenerative medicine, and disease modeling. We offer ready-to-use organoid cultures and customized assay development for oncology and immunotherapy research.

Basic company reference. Business areas, products and practical answers have not been added.

- Canonical entity: https://directory.readyscan.ai/entities/lambda-biologics-gmbh-q135390084
- Website listed in the source snapshot: https://afs.lambda-bio.com/
- Category: [Enterprises](https://directory.readyscan.ai/directory/enterprises)
- Machine record: https://directory.readyscan.ai/discovery/entities/lambda-biologics-gmbh-q135390084.json
- Material fingerprint: fnv1a64:d4b68ca7bdfb2102
- Entity revision: fnv1a64:9ac603b55b61fabf
- Published: 2026-07-29
- Modified: 2026-07-29

## Company sources
- [Lambda Biologics GmbH — Wikidata Q135390084](https://www.wikidata.org/wiki/Special:EntityData/Q135390084.json?revision=2385748401) — Wikidata

## Data access & reuse
- [Wikidata data access](https://www.wikidata.org/wiki/Help:Data_access) — Wikidata
- [Wikidata reuse permission](https://www.wikidata.org/wiki/Wikidata:Licensing) — Wikidata
- [CC0 1.0 Universal](https://creativecommons.org/publicdomain/zero/1.0/) — Wikidata

## Continue reading
- Discover the bounded graph: https://readyscan.ai/api/v1/ai-search/discovery
- Retrieve this entity evidence: https://readyscan.ai/api/v1/ai-search/entities/lambda-biologics-gmbh-q135390084/evidence

## Publication boundary
- This public-sourced record brings together company information and its sources. It is not an owner-managed profile.
- Publication does not guarantee crawling, indexing, training inclusion, citation, recommendation, referral, or revenue.